Massachusetts Financial Services’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $877M | Buy |
6,651,833
+370,224
| +6% | +$48.8M | 0.28% | 95 |
|
|
2026
Q1 | $910M | Buy |
6,281,609
+2,058,305
| +49% | +$288M | 0.31% | 88 |
|
|
2025
Q4 | $518M | Buy |
4,223,304
+4,113,999
| +3,764% | +$500M | 0.17% | 137 |
|
|
2025
Q3 | $12.1M | Sell |
109,305
-4,986
| -4% | -$567K | ﹤0.01% | 676 |
|
|
2025
Q2 | $12.7M | Buy |
114,291
+20,005
| +21% | +$2.13M | ﹤0.01% | 660 |
|
|
2025
Q1 | $10.6M | Buy |
94,286
+18,368
| +24% | +$1.9M | ﹤0.01% | 656 |
|
|
2024
Q4 | $7.01M | Buy |
75,918
+511
| +0.7% | +$46K | ﹤0.01% | 672 |
|
|
2024
Q3 | $6.32M | Sell |
75,407
-10,397
| -12% | -$793K | ﹤0.01% | 663 |
|
|
2024
Q2 | $5.89M | Buy |
85,804
+522
| +0.6% | +$34.8K | ﹤0.01% | 672 |
|
|
2024
Q1 | $6.25M | Buy |
85,282
+295
| +0.3% | +$22.7K | ﹤0.01% | 654 |
|
|
2023
Q4 | $6.88M | Sell |
84,987
-193,573
| -69% | -$15.1M | ﹤0.01% | 643 |
|
|
2023
Q3 | $20.9M | Buy |
278,560
+3,228
| +1% | +$248K | 0.01% | 556 |
|
|
2023
Q2 | $21.2M | Sell |
275,332
-108,468
| -28% | -$8.65M | 0.01% | 549 |
|
|
2023
Q1 | $31.8M | Sell |
383,800
-150,760
| -28% | -$12.5M | 0.01% | 495 |
|
|
2022
Q4 | $45.9M | Sell |
534,560
-30,003
| -5% | -$2.38M | 0.02% | 457 |
|
|
2022
Q3 | $34.8M | Sell |
564,563
-11,465
| -2% | -$723K | 0.01% | 502 |
|
|
2022
Q2 | $35.6M | Buy |
576,028
+11,850
| +2% | +$734K | 0.01% | 494 |
|
|
2022
Q1 | $33.5M | Buy |
564,178
+303,523
| +116% | +$19.4M | 0.01% | 530 |
|
|
2021
Q4 | $18.9M | Buy |
260,655
+82,245
| +46% | +$5.66M | 0.01% | 609 |
|
|
2021
Q3 | $12.5M | Sell |
178,410
-283,556
| -61% | -$19.9M | ﹤0.01% | 657 |
|
|
2021
Q2 | $31.8M | Buy |
461,966
+45,683
| +11% | +$3.05M | 0.01% | 568 |
|
|
2021
Q1 | $26.9M | Sell |
416,283
-13,024
| -3% | -$840K | 0.01% | 575 |
|
|
2020
Q4 | $25M | Buy |
429,307
+72,915
| +20% | +$4.4M | 0.01% | 568 |
|
|
2020
Q3 | $22.5M | Buy |
+356,392
| New | +$24.7M | 0.01% | 558 |
|
|
2020
Q1 | – | Sell |
-5,739
| Closed | -$373K | – | 811 |
|
|
2019
Q4 | $373K | Sell |
5,739
-667
| -10% | -$43.4K | ﹤0.01% | 794 |
|
|
2019
Q3 | $406K | Buy |
6,406
+558
| +10% | +$36.5K | ﹤0.01% | 803 |
|
|
2019
Q2 | $395K | Buy |
5,848
+208
| +4% | +$13.7K | ﹤0.01% | 823 |
|
|
2019
Q1 | $367K | Sell |
5,640
-836
| -13% | -$55.6K | ﹤0.01% | 823 |
|
|
2018
Q4 | $405K | Sell |
6,476
-1,255
| -16% | -$87.7K | ﹤0.01% | 825 |
|
|
2018
Q3 | $597K | Buy |
7,731
+2,728
| +55% | +$206K | ﹤0.01% | 816 |
|
|
2018
Q2 | $354K | Sell |
5,003
-774
| -13% | -$54.7K | ﹤0.01% | 821 |
|
|
2018
Q1 | $436K | Sell |
5,777
-1,719
| -23% | -$137K | ﹤0.01% | 811 |
|
|
2017
Q4 | $537K | Buy |
7,496
+1,425
| +23% | +$108K | ﹤0.01% | 810 |
|
|
2017
Q3 | $492K | Sell |
6,071
-1,358,988
| -100% | -$104M | ﹤0.01% | 805 |
|
|
2017
Q2 | $96.6M | Sell |
1,365,059
-362,389
| -21% | -$24.1M | 0.04% | 269 |
|
|
2017
Q1 | $117M | Sell |
1,727,448
-720,025
| -29% | -$50.6M | 0.05% | 235 |
|
|
2016
Q4 | $175M | Sell |
2,447,473
-60,740
| -2% | -$4.51M | 0.09% | 196 |
|
|
2016
Q3 | $198M | Sell |
2,508,213
-188,363
| -7% | -$15.3M | 0.1% | 189 |
|
|
2016
Q2 | $225M | Sell |
2,696,576
-169,031
| -6% | -$15M | 0.11% | 173 |
|
|
2016
Q1 | $263M | Buy |
2,865,607
+348,593
| +14% | +$31.4M | 0.14% | 156 |
|
|
2015
Q4 | $255M | Buy |
2,517,014
+105,818
| +4% | +$11M | 0.14% | 158 |
|
|
2015
Q3 | $237M | Buy |
2,411,196
+653,014
| +37% | +$72.5M | 0.13% | 154 |
|
|
2015
Q2 | $206M | Buy |
1,758,182
+164,961
| +10% | +$18M | 0.1% | 179 |
|
|
2015
Q1 | $156M | Sell |
1,593,221
-411,753
| -21% | -$41.8M | 0.08% | 204 |
|
|
2014
Q4 | $189M | Sell |
2,004,974
-786,096
| -28% | -$81.3M | 0.1% | 187 |
|
|
2014
Q3 | $297M | Sell |
2,791,070
-153,905
| -5% | -$15.1M | 0.16% | 143 |
|
|
2014
Q2 | $244M | Sell |
2,944,975
-2,473,366
| -46% | -$193M | 0.13% | 163 |
|
|
2014
Q1 | $384M | Sell |
5,418,341
-1,812,260
| -25% | -$142M | 0.21% | 105 |
|
|
2013
Q4 | $543M | Sell |
7,230,601
-556,365
| -7% | -$38.7M | 0.3% | 83 |
|
|
2013
Q3 | $490M | Buy |
7,786,966
+1,522,873
| +24% | +$91M | 0.3% | 83 |
|
|
2013
Q2 | $321M | Buy |
+6,264,093
| New | +$327M | 0.22% | 98 |
|
Other funds holding GILD
Massachusetts Financial Services's GILD Position: Q2 2026 in Review
Massachusetts Financial Services increased its Gilead Sciences (GILD) stake by 5.9% in Q2 2026, buying an estimated $48.8M and bringing the position to 6,651,833 shares worth $877M. The position accounts for 0.28% of the portfolio, ranked #95.
Massachusetts Financial Services first reported a position in GILD in Q2 2013 and has held it in 51 quarters since. The position peaked at $910M in Q1 2026. 1,412 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Massachusetts Financial Services held 6,651,833 shares of Gilead Sciences worth $877M as of Q2 2026.
- Massachusetts Financial Services bought 370,224 Gilead Sciences shares in Q2 2026, an estimated $48.8M.
- Gilead Sciences made up 0.28% of Massachusetts Financial Services's portfolio in Q2 2026, its #95 holding.
- Massachusetts Financial Services first reported a position in Gilead Sciences in Q2 2013 and has held it in 51 quarters since.
- Massachusetts Financial Services's Gilead Sciences position peaked at $910M in Q1 2026.
- 1,412 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Massachusetts Financial Services's 13F filing for Q2 2026, filed 3 Aug 2026.